Search
for
Sort by
Research 30 of 100
- Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report
- Protective mitophagy in human hypoxic cardiomyocytes: mechanistic insights into SGLT2 inhibitor Dapagliflozin cardioprotection in ischemic injury
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Drug Repurposing Patent Applications April–June 2021
- Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
- FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- PCSK9: From Nature’s Loss to Patient’s Gain
- Mechanisms of autophagy and their implications in dermatological disorders
- Disruption of tubular Flcn expression as a mouse model for renal tumor induction
- THU372 Finasteride Induced Hyperglycemia
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells
- Subject Index
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- From Anti-Aging Medicine to Precision Healthspan Pharmacology: Evidence Domains, Monitoring Requirements, and Practical Boundaries
- Semaglutide and the Skin: An Overview of Current Evidence